EFFECT OF KETAMINE AND NALBUPHINE ON SHIVERING AFTER SPINAL ANESTHESIA

Authors

  • Mubashir Akram Department of Urology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, University of Health Sciences Lahore, Pakistan
  • Nazish Masood Department of Anesthesia, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, University of Health Sciences Lahore, Pakistan
  • Muhammad Anwar Department of Community Medicine, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, University of Health Sciences Lahore, Pakistan

Keywords:

Ketamine, Nalbuphine, Spinal Anesthesia, Shivering.

Abstract

Background: Intraoperative shivering occurs in significant proportions of patients undergoing spinal anesthesia, and may also
cause complications, especially in the patients with coronary artery disease, because of associated increase in oxygen
.
consumption. Objective: To compare the effect of ketamine and nalbuphine on shivering after spinal anesthesia. Methodology:
Study design: Quasi experimental study. This study was conducted in operation theater phase 2 of Sheikh Zayed Hospital, Rahim
th th Yar Khan. Duration: From 6 September 2016 to 13 February 2017. The patients under going non obstetrical surgery under
spinal anesthesia were included in this study. The data was collected from 67 patients on which we compared the effect of
ketamine (group A) and nalbuphine (group B) on shivering after spinal anaesthesia. The patients undergoing gynaecological and
obstetrics procedures were excluded from this study. The data was entered and analyzed by using SPSS 20. Results: In our study,
total 67 non-obstetrical patients were included undergoing spinal anesthesia. Age range was 15 to 80 years. Out of 67 patients
ketamine was given to 34(82.9%) males and 7(17.1%) females and nalbuphine was given to 21(80.8%) males and 5(19.2%)
females. In group A shivering stopped by ketamine was 90.2% and in group B shivering stopped by nalbuphine was 69.2%.
Conclusion: Ketamine showed better effect on shivering after spinal anesthesia as compared to nalbuphine in non-obstetrical
patients undergoing elective surgical procedures.

Downloads

Published

2017-11-01